Phase
Condition
Asthma
Lung Disease
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Male or female patients aged 18 years or older with a physician's confirmeddiagnosis of severe eosinophilic, uncontrolled asthma.
Severe uncontrolled eosinophilic asthma requiring high-dose* inhaled corticosteroidplus long-acting β adrenoceptor agonist as maintenance treatment.
Patients who have been prescribed but not yet initiated treatment with benralizumab (Fasenra®) according to local approved prescribing information prior to signedinformed consent.
Provision of the signed written informed consent form (ICF) indicating that theyunderstand the purpose of the study and procedures required for participation.
Patients must be able and willing to read and comprehend written instructions andcomplete the paper PRO questionnaires required by the protocol.
Exclusion
Exclusion Criteria:
Clinically important pulmonary diseases other than asthma including chronicobstructive pulmonary disease (as the main diagnosis), bronchiectasis, idiopathicpulmonary fibrosis, pulmonary hypertension, alpha-1-antitrypsin-deficiency, andmalignancy of any kind (NB: the following conditions are permitted: nasal polyposis,allergic rhinitis, atopic dermatitis, non-idiopathic pulmonary fibrosis).
Currently enrolled in an interventional clinical study except patients being inparallel documented in a national asthma registry
An acute or chronic condition that, in the investigator's opinion, would limit thepatients' ability to complete questionnaires or participate in this study or impactthe interpretations of results.
Concurrent biologics for asthma are not allowed. Acceptable wash-out periods forother asthma biologics: ≥30 days from the last dose of the previous biologic.
Women who are currently pregnant, breastfeeding, or lactating
Study Design
Study Description
Connect with a study center
Research Site
São Paulo, Sao Paulo 05403-000
BrazilSite Not Available
Research Site
Medellin, Antioquia 50621
ColombiaSite Not Available
Research Site
Soledad, Atlantico 83001
ColombiaSite Not Available
Research Site
Floridablanca, Santander 681004
ColombiaSite Not Available
Research Site
Bogota,
ColombiaSite Not Available
Research Site
Bucaramanga,
ColombiaSite Not Available
Research Site
Cali, 760042
ColombiaSite Not Available
Research Site
Ibague,
ColombiaSite Not Available
Research Site
Pereira,
ColombiaSite Not Available
Research Site
Ensanche la Fe, Santo Domingo 10514
Dominican RepublicSite Not Available
Research Site
Santiago,
Dominican RepublicSite Not Available
Research Site
Santiago de los Caballeros, 51000
Dominican RepublicSite Not Available
Research Site
Santo Domingo,
Dominican RepublicSite Not Available
Research Site
Ahmedabad,
IndiaSite Not Available
Research Site
Ajmer,
IndiaSite Not Available
Research Site
Chennai,
IndiaSite Not Available
Research Site
Delhi,
IndiaSite Not Available
Research Site
Hyderabad,
IndiaSite Not Available
Research Site
Jaipur,
IndiaSite Not Available
Research Site
Kolkata,
IndiaSite Not Available
Research Site
Pune,
IndiaSite Not Available
Research Site
Secundrabad,
IndiaSite Not Available
Research Site
Vadodara,
IndiaSite Not Available
Research Site
Shamiya, Shamiya-Kuwait 8VGW+6RW
KuwaitSite Not Available
Research Site
Sabah Al Salem,
KuwaitSite Not Available
Research Site
Muscat,
OmanSite Not Available
Research Site
Doha,
QatarSite Not Available
Research Site
Jeddah,
Saudi ArabiaSite Not Available
King fahad medical city
Riyadh, 11525
Saudi ArabiaActive - Recruiting
Research Site
Riyadh,
Saudi ArabiaSite Not Available
Research Site
Abu Dhabi,
United Arab EmiratesSite Not Available
Research Site
Al Ain,
United Arab EmiratesSite Not Available
Research Site
Dubai,
United Arab EmiratesSite Not Available
Research Site
Jeddah, 23214
United Arab EmiratesSite Not Available
Research Site
Riyadh,
United Arab EmiratesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.